跳至主要内容
临床试验/NCT06248307
NCT06248307已完成不适用

Evaluación Del Efecto de la Ingesta de Una Barrita Con Alto Contenido de proteína Sobre el Peso y la Salud Osteoarticular

Clinica Universidad de Navarra, Universidad de Navarra2 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2023年11月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
102
试验地点
2
主要终点
Change in fat mass

研究概览

简要总结

The goal of this intervention study is to evaluate the efficacy in subjects with overweight or obesity of protein bars consumption. The main questions it aims to answer are:

  • Does the regular consumption of these protein bars help to loose weight?
  • Does the regular consumption of these protein bars help to improve the osteoarticular health? Participants will be asked to follow the indications of consumption of the bars togather with healthy nutritional advice during 16 weeks.

Researchers will compare exparimental Versus placebo groups to see if weight is lost in similar or different ways.

详细描述

The intervention is designed to evaluate the efficacy of the consumption of a protein bar vs placebo on weight control and osteoarticular health.

For this purpose, a total of 102 subjects will be randomised to either the experimental group or the placebo group, the only stratification performed will be acording to sex.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
35 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • BMI between 25 and 37.5 kg/m2
  • Normal physical examination and vital signs according to clinical examiners.
  • Chronic pharmacological treatment is permitted if dosage is stable within at least three months prior the start of the intervention.

排除标准

  • Any funcitonal or structural impairment in digestive system (hitus hernia, ulcers, inflammatory bowel disease, etc.)
  • Excessive alcohol consumption (> 14 units/week in women and > 20 units per week in men)
  • Bariatric surgery or similar
  • Arthritis, hepatic diseases, cancer.
  • Alergy to any component of the products
  • Subjects presenting any cognitive or psichiatric impairment, that may impel them to follow the protocol.
  • Subjects following any weight loss program

结局指标

主要结局

Change in fat mass

时间窗: 16 weeks

Body composition . Change in fat mass between baseline and end of intervention

Ponderal evolution

时间窗: 16 weeks

Change in body weight between baseline and end of intervention

Change in fat-free mass

时间窗: 16 weeks

Body composition . Change in fat-free mass between baseline and end of intervention

次要结局

  • Osteoarticular changes(16 weeks)
  • Plasma P2P and CTX-II levels(16 weeks)

研究者

发起方
Clinica Universidad de Navarra, Universidad de Navarra
申办方类型
Other
责任方
Principal Investigator
主要研究者

Santiago Navas

Principal Investigator

University of Navarra

研究点 (2)

Loading locations...

相似试验

Evaluation of Protein Bars on Weight Management and... | 临床试验